Tranexamic acid: from trauma to routine perioperative use : Current Opinion in
Anesthesiology Tranexamic acid: from trauma to routine perioperative use : Current Opinion …

Tranexamic acid (TXA), a synthetic lysine analogue, is a potent antifibrinolytic agent that
inhibits both plasminogen and plasmin. Tranexamic acid gained worldwide recognition in …

Tranexamic acid (TXA) is a potent antifibrinolytic with documented efficacy in reducing blood
loss and allogeneic red blood cell transfusion in several clinical settings. With a growing …

Background. Perioperative tranexamic acid (TXA) use can reduce bleeding and transfusion
requirements in several types of surgery, but level I evidence proving its effectiveness in …

Background Tranexamic acid (TXA) reduces transfusion in a wide range of surgical
populations, although its real‐world use in non‐cardiac surgeries has not been well …

experts at drug dosing, and we likely have more experience doing so than any other
specialty in medicine. With anesthetic drugs such as fentanyl or propofol, we often dose by …

Background Tranexamic acid (TXA) reduces blood transfusion in surgery but the extent of
the reduction in blood loss and how it relates to the dose of TXA is unclear. Methods A …

BACKGROUND Tranexamic acid (TXA) is an inexpensive therapy effective at minimizing
perioperative blood loss and transfusion. However, it remains underutilized due to safety …

Tranexamic acid (TXA) significantly reduces blood loss in a wide range of surgical
procedures and improves survival rates in obstetric and trauma patients with severe …

Blood loss during surgical procedures poses a grave risk to the patient, but transfusion is
costly and associated with adverse outcomes. Antifibrinolytics, however, offer an economical …